Charles Schwab Investment Management Inc Dexcom Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,825,206 shares of DXCM stock, worth $249 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,825,206
Previous 2,734,155
3.33%
Holding current value
$249 Million
Previous $183 Million
19.9%
% of portfolio
0.04%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding DXCM
# of Institutions
1,041Shares Held
356MCall Options Held
5.51MPut Options Held
5.61M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4.18 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.04 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.58 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.29 Billion0.9% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...